Evaluation of concomitant gynecological pathology in group of patients of reproductive age with tumors and tumor formations

Abstract

According to modern literature, the frequency of preoperative diagnostic errors for tumour-like formations is 30.9–45.6%, for malignant ovarian tumors is 25.0–51.0%. The complexity of this situation is asymptomatic tumor in the ovaries and failure to identify a neoplastic process, which is especially important for young women, as well as ease the transition of tumors from one category to another (evolution of the tumor) and the source of the aggressive behavior of the tumor. The purpose of our study was to evaluate the history of concomitant gynecological pathology in a group of patients of reproductive age with ovarian tumors and tumoroid formations, as a predisposing factor for the development of neoplastic process in the ovaries. In our work, we collected and processed complaints and data of obstetric and gynecological anamnesis of 168 patients of reproductive age (18–40 years), operated on the basis of the Department of oncogynecology for tumors and ovarian tumours in the Samara Regional Clinical Oncology Dispensary from 2012 to 2015. We can conclude that since the prognosis of neoplastic process in the ovaries is generally good with timely detection and this disease occurs mainly in women of reproductive age, doctors need to know that when assessing the parity and the presence of gynecological pathology at the moment or in anamnesis, it is not possible to identify alarming risk factors for the development of cancer in the ovaries.

Giant foam-like macrophages in advanced ovarian cancer

“…In 2020, 313,959 cases of ovarian cancer were detected, representing 3.4 % of all cancers in women and 207,252 deaths occurred [3]. The urgency of the OC research derives from the large number of issues associated with late-stage diagnosis, difficulties in choosing treatment tactics, low treatment efficacy and a high proportion of relapses [1,4,5]. There are no effective criteria for diagnosing OC in the early stages, and screening tests have limited sensitivity.…”